Management of systemic sclerosis: British Society for Rheumatology guideline scope.
Author
Denton CPDe Lorenzis E
Roblin E
Goldman N
Alcacer-Pitarch B
Blamont E
Buch M
Carulli M
Cotton C
Del Galdo F
Derrett-Smith E
Douglas K
Farrington S
Fligelstone K
Gompels L
Griffiths B
Herrick A
Hughes M
Pain C
Pantano G
Pauling J
Prabu A
O'Donoghue N
Renzoni E
Royle J
Samaranayaka M
Spierings J
Tynan A
Warburton L
Ong V
Affiliation
University College London; University of Leeds; Royal Free London NHS Foundation Trust; The Dudley Group NHS Foundation Trust et alPublication date
14/03/2023Subject
Rheumatology
Metadata
Show full item recordAbstract
This guideline will provide a practical roadmap for management of SSc that builds upon the previous treatment guideline to incorporate advances in evidence-based treatment and increased knowledge about assessment, classification and management. General approaches to management as well as treatment of specific complications will be covered, including lung, cardiac, renal and gastrointestinal tract disease, as well as RP, digital vasculopathy, skin manifestations, calcinosis and impact on quality of life. It will include guidance related to emerging approved therapies for interstitial lung disease and account for National Health Service England prescribing policies and national guidance relevant to SSc. The guideline will be developed using the methods and processes outlined in Creating Clinical Guidelines: Our Protocol. This development process to produce guidance, advice and recommendations for practice has National Institute for Health and Care Excellence accreditation. The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology.Citation
Denton CP, De Lorenzis E, Roblin E, Goldman N, Alcacer-Pitarch B, Blamont E, Buch M, Carulli M, Cotton C, Del Galdo F, Derrett-Smith E, Douglas K, Farrington S, Fligelstone K, Gompels L, Griffiths B, Herrick A, Hughes M, Pain C, Pantano G, Pauling J, Prabu A, O'Donoghue N, Renzoni E, Royle J, Samaranayaka M, Spierings J, Tynan A, Warburton L, Ong V. Management of systemic sclerosis: British Society for Rheumatology guideline scope. Rheumatol Adv Pract. 2023 Mar 14;7(1):rkad022. doi: 10.1093/rap/rkad022. PMID: 36923262; PMCID: PMC10010890.Type
ArticlePMID
36923262Publisher
Oxford University Pressae974a485f413a2113503eed53cd6c53
10.1093/rap/rkad022